|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3-4
|
|
pubmed:dateCreated |
2008-10-30
|
|
pubmed:abstractText |
The p160 nuclear receptor coactivator, AIB1 (amplified in breast cancer 1), is frequently overexpressed in human breast cancer and has been shown to be associated with tamoxifen resistance. The present study aimed to investigate the role of AIB1 in tamoxifen resistance of breast cancer cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Histone Acetyltransferases,
http://linkedlifedata.com/resource/pubmed/chemical/NCOA3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Receptor Coactivator 3,
http://linkedlifedata.com/resource/pubmed/chemical/PSEN2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Presenilin-2,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/hydroxytamoxifen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
159-68
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18827493-Base Sequence,
pubmed-meshheading:18827493-Blotting, Western,
pubmed-meshheading:18827493-Breast Neoplasms,
pubmed-meshheading:18827493-Cell Cycle,
pubmed-meshheading:18827493-Cell Proliferation,
pubmed-meshheading:18827493-Drug Resistance, Neoplasm,
pubmed-meshheading:18827493-Estradiol,
pubmed-meshheading:18827493-Estradiol Antagonists,
pubmed-meshheading:18827493-Estrogen Receptor alpha,
pubmed-meshheading:18827493-Histone Acetyltransferases,
pubmed-meshheading:18827493-Humans,
pubmed-meshheading:18827493-Molecular Sequence Data,
pubmed-meshheading:18827493-Nuclear Receptor Coactivator 3,
pubmed-meshheading:18827493-Presenilin-2,
pubmed-meshheading:18827493-RNA, Messenger,
pubmed-meshheading:18827493-RNA, Small Interfering,
pubmed-meshheading:18827493-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18827493-Tamoxifen,
pubmed-meshheading:18827493-Trans-Activators,
pubmed-meshheading:18827493-Transcription, Genetic,
pubmed-meshheading:18827493-Tumor Cells, Cultured
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
|
|
pubmed:affiliation |
Department of General Surgery, Qilu Hospital, Shandong University, Jinan, PR China.
|
|
pubmed:publicationType |
Journal Article
|
